Detailed evaluation of dyskinesias using multiple endpoints in a randomized, placebo-controlled trial of Parkinson's disease patients with motor fluctuations

被引：0
|
作者：
Kenney, C.
Kieburtz, K.
Olanow, W.
Bandak, S.
机构：
来源：
MOVEMENT DISORDERS | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2097
引用
收藏
页码：S693 / S693
页数：1
相关论文
共 50 条
  • [21] Electronic diaries to assess motor fluctuations and dyskinesias in Parkinson's disease patients
    Guedes, LC
    Marino, B
    Ferreira, J
    Rosa, MM
    Noronha, A
    Sampaio, C
    MOVEMENT DISORDERS, 2005, 20 : S141 - S142
  • [22] Electronic diaries to assess motor fluctuations and dyskinesias in Parkinson's disease patients
    Guedes, L. Correia
    Ferreira, J.
    Rosa, M.
    Marino, B.
    Sampaio, C.
    MOVEMENT DISORDERS, 2006, 21 : S542 - S542
  • [23] A Randomized, Double-Blind, Placebo-Controlled Trial of Camicinal in Parkinson's Disease
    Marrinan, Sarah L.
    Otiker, Tal
    Vasist, Lakshmi S.
    Gibson, Rachel A.
    Sarai, Bhopinder K.
    Barton, Matthew E.
    Richards, Duncan B.
    Hellstrom, Per M.
    Nyholm, Dag
    Dukes, George E.
    Burn, David J.
    MOVEMENT DISORDERS, 2018, 33 (02) : 329 - 332
  • [24] Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease
    Metman, LV
    Del Dotto, P
    van den Munckhof, P
    Fang, J
    Mouradian, MM
    Chase, TN
    NEUROLOGY, 1998, 50 (05) : 1323 - 1326
  • [25] Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease
    Metman, LV
    Del Dotto, P
    van den Munckhof, P
    Fang, J
    Mouradian, MM
    Chase, TN
    NERVENHEILKUNDE, 1998, 17 (10) : 480 - 484
  • [26] Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations
    Jankovic, J
    MOVEMENT DISORDERS, 2005, 20 : S11 - S16
  • [27] Creatine supplementation in Parkinson disease:: A placebo-controlled randomized pilot trial
    Bender, A.
    Koch, W.
    Elstner, M.
    Schombacher, Y.
    Bender, J.
    Moeschl, M.
    Gekeler, F.
    Mueller-Myhsok, B.
    Gasser, T.
    Tatsch, K.
    Klopstock, T.
    NEUROLOGY, 2006, 67 (07) : 1262 - 1264
  • [28] The ocean (opicapone effect on motor fluctuations and associated pain) study in Parkinson's disease: Design and rationale of a randomized double-blind placebo-controlled trial
    Chaudhuri, K. Ray
    Odin, Per
    Ferreira, Joaquim
    Antonini, Angelo
    Rascol, Olivier
    Kurtis, Monica
    Storch, Alexander
    Bannister, Kirsty
    Costa, Raquel
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 266 - 267
  • [29] The OCEAN (OpiCapone Effect on motor fluctuations and associated pAiN) study in Parkinson's disease: design and rationale of a randomized double-blind placebo-controlled trial
    Chaudhuri, K.
    Odin, P.
    Ferreira, J.
    Antonini, A.
    Rascol, O.
    Kurtis, M.
    Storch, A.
    Bannister, K.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S164 - S165
  • [30] Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
    Katzenschlager, Regina
    Poewe, Werner
    Rascol, Olivier
    Trenkwalder, Claudia
    Deuschl, Gunther
    Chaudhuri, K. Ray
    Henriksen, Tove
    van Laar, Teus
    Spivey, Kevin
    Vel, Senthil
    Staines, Harry
    Lees, Andrew
    LANCET NEUROLOGY, 2018, 17 (09): : 749 - 759
12345